Breast cancer after Hodgkin's disease
Cutuli, B.
Journal de Gynecologie Obstetrique et Biologie de la Reproduction 25(3): 301-302
1996
ISSN/ISBN: 0368-2315 PMID: 8767231 Document Number: 461409
Document emailed within 1 workday
Related Documents
Wahner-Roedler, D.L.; Petersen, I.A. 2004: Risk of breast cancer and breast cancer characteristics in women after treatment for Hodgkin lymphoma Drugs of Today 40(10): 865-879Jakovljevic, M.; Gutzwiller, F.; Schwenkglenks, M.; Milovanovic, O.; Rancic, N.; Varjacic, M.; Stojadinovic, D.; Dagovic, A.; Matter-Walstra, K. 2014: Costs differences among monoclonal antibodies-based first-line oncology cancer protocols for breast cancer, colorectal carcinoma and non-Hodgkin's lymphoma Journal of BUON: Official Journal of the Balkan Union of Oncology 19(4): 1111-1120
Ravetta, A. 1971: Case of Hodgkin's disease associated with breast carcinoma Minerva Medica 62(59): 2892-2894
Schultz, D.C.; Bazel, S.; Wright, L.M.; Tucker, S.; Lange, M.K.; Tachovsky, T.; Longo, S.; Niedbala, S.; Alhadeff, J.A. 1994: Western blotting and enzymatic activity analysis of cathepsin D in breast tissue and sera of patients with breast cancer and benign breast disease and of normal controls Cancer Research 54(1): 48-54
Henry-Amar, M.; Somers, R. 1990: Survival outcome after Hodgkin's disease: a report from the international data base on Hodgkin's disease Seminars in Oncology 17(6): 758-768
Balázs, L. 1990: Immunohistology of Hodgkin's disease. use of monoclonal antibodies in the analysis of the pathomorphology of Hodgkin's disease Morphologiai Es Igazsagugyi Orvosi Szemle 30(3): 182-190
Lipkus, I.M.; Iden, D.; Terrenoire, J.; Feaganes, J.R. 1999: Relationships among breast cancer concern, risk perceptions, and interest in genetic testing for breast cancer susceptibility among African-American women with and without a family history of breast cancer Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 8(6): 533-539
Page, D.L.; Dupont, W.D. 1992: Benign breast disease: indicators of increased breast cancer risk Cancer Detection and Prevention 16(2): 93-97
Socolov, D.; Anghelache, I.; Ilea, C.; Socolov, R.; Carauleanu, A. 2015: Benign breast disease and the risk of breast cancer in the next 15 years Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 119(1): 135-140
Nasca, P.C.; Lawrence, C.E.; Greenwald, P.; Chorost, S.; Arbuckle, J.T.; Paulson, A. 1980: Relationship of hair dye use, benign breast disease, and breast cancer Journal of the National Cancer Institute 64(1): 23-28
Singh, N.K.; Das, U.N.; Srivastava, P.K. 1987: Essential fatty acids and cancer with particular reference to Hodgkin's disease Journal of the Association of Physicians of India 35(2): 137-138
Kristiansen, I.S.; Christensen, P.M.; Gyrd-Hansen, D. 2005: Benign breast disease and breast cancer New England Journal of Medicine 353(17): 1856-1858; Author Reply 1856-1858
Hoppe, R.T. 2002: Hodgkin's disease: a model for interdisciplinary cancer management: 2002 Janeway lecture Cancer Journal 8(6): 425-431
Gams, R.A.; Durant, J.R.; Bartolucci, A.A. 1982: Chemotherapy for advanced Hodgkin's disease: conclusions from the Southeastern Cancer Study Group Cancer Treatment Reports 66(4): 899-905
1997: Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium Lancet 349(9064): 1505-1510
Aeberhard, P.; Schröder, R.; Joss, J. 1981: Staging laparotomy in Hodgkin's disease and non-Hodgkin lymphomas: indication, technic and results Therapeutische Umschau. Revue Therapeutique 38(9): 875-880
Montalban, C.; Bellas, C.; Rodriguez-Garcia, J.L.; Aguado, M.; Fernandez-Muñoz, R. 1991: Non-Hodgkin's lymphoma after prolonged remission of Hodgkin's disease in an HIV-infected patient Annals of Oncology: Official Journal of the European Society for Medical Oncology 2(8): 585-587
Rysenga, E.; Linden, M.D.; Carey, J.L.; Ross, C.W.; Schnitzer, B.; Sawdyk, M.; Maeda, K. 1995: Peripheral T-cell non-Hodgkin's lymphoma following treatment of nodular lymphocyte predominance Hodgkin's disease Archives of Pathology and Laboratory Medicine 119(1): 88-91
István, L.; Balázs, L.; Brittig, F.; Pócza, K.; Szentcsiki, M.; Brenner, F. 1985: Incidence of highly malignant immunoblastic non-Hodgkin lymphoma in patients with Hodgkin's disease in remission Orvosi Hetilap 126(21): 1267-1272
Bucerius, J.; Herkel, C.; Joe, A.Y.; Altehoefer, C.; Finke, J.; Moser, E.; Reinhardt, M.J. 2006: (18)F-FDG PET and conventional imaging for assessment of Hodgkin's disease and non Hodgkin's lymphoma. An analysis of 193 patient studies Nuklearmedizin. Nuclear medicine 45(3): 105-10; quiz N25-6